← SynDRA
DIPHEMANIL
SynDRA canonical compound SYN0023545 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | CHRM3 |
| Mechanism of action | Acetylcholine receptor antagonist |
| Indication | spasms |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- CHRM1 ANTAGONIST
- Muscarinic acetylcholine receptor M1 antagonist
- CHRM1 MODULATOR
Drug classes
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Parasympatholytics
- Peripheral Nervous System Agents
- Respiratory System Agents
ATC classes
- A03A · DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
- ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS
Cross-references
Synonyms
- biphemanil
- diphemanil methosulfate
- diphemanil methyl sulfate
- diphemanil metilsulfate
- diphenmanil methylsulfate
- diphenmethanil
- diphenmethanil methylsulfate
- diphemanil methylsulfate
- Diphemanil cation
- Diphemanil ion
- Diphemanil [WHO-DD]
- Q26TX1UD0W
- 4-(Diphenylmethylene)-1,1-dimethylpiperidinium
- Piperidinium, 4-(diphenylmethylene)-1,1-dimethyl-
- MLS002154192
- CAS-62-97-5
- NCGC00016283-01
- SMR001233482
- UNII-Q26TX1UD0W
- SPBio_002218
- Prestwick0_000079
- Prestwick1_000079
- Prestwick2_000079
- Prestwick3_000079
- cid_6126
- BSPBio_000297
- BPBio1_000327
- CHEMBL1201340
- DTXSID7046968
- BDBM74260
- CHEBI:93636
- ZINC1482039
- DB13720
- NCGC00016283-02
- NCGC00016283-03
- AB00513801
- 1,1-Dimethyl-4-benzhydrylidenepiperidine-1-ium
- AB00513801_06
Look up DIPHEMANIL in the interactive SynDRA portal →